If you find any errors or omissions in these Guidelines, or feel that something in them needs to change, write to:
DameClinGuide.feedback@casa.gov.au
Please include details of the page on which you wish to provide feedback.
Thank you for your assistance in ensuring that these Guidelines are up to date and correct.
There is a wide range of medical treatments and investigations that may affect the ability to fly safely. If there are side effects or complications following the treatment/investigation, then the recommended stand-down period should be extended.
The recommended no-flying/no-controlling time relates to treatment or investigation only. The medical matter or reason for the procedure must be considered separately – refer to your DAME or CASA.
These recommendations apply to all medical certificate class holders.
The times stated below assume the certificate holder is feeling well afterwards and the treatment/procedure/investigation is uncomplicated.
If the certificate holder is unwell or there are medical complications, then you must refer to your DAME or CASA.
Treatment/Investigation | Recommended minimum no-flying / no-controlling | Comments/Reasons |
---|---|---|
Routine blood tests | No restriction on flying/controlling | No acute effect on circulating blood volume |
Local anaesthetics (including dental) | 12 hours | Pain, distraction, delayed hypersensitivity |
Vaccinations | 12 hours | Delayed hypersensitivity reactions |
Allergy desensitisation injections | 24 hours | Delayed hypersensitivity reactions |
Blood & plasma donation /venesection | 24 hours | Increased risk of hypoxia and hypotension |
Steroid joint injection | 24 hours | Underlying condition must be stable/resolved |
Sedation (gastroscopy, colonoscopy, in-chair dental procedures) | 24 hours | Cognitive effects of medications used |
General anaesthetic (including spinal or epidural) |
48 hours (+ recovery from type of surgery) | Cognitive effects of medications used |
The Clinical Practice Guideline is provided by way of guidance only and subject to the Clinical practice guidelines disclaimer